Publication | Closed Access

Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat

Cerebrovascular DiseasePharmacotherapyCerebral Vascular RegulationThrombosisStrokeBrain InjuryNeurologyAtherosclerosisIschemic SyndromeNeurological DeficitsInfarct VolumeNeuropharmacologyCerebral Blood FlowReperfusion InjuryPharmacologyIschemic StrokeStroke-related ConditionEmbolic StrokeMedicine